CASTOR OIL

INSTRUCTION FOR MEDICAL USE OF THE MEDICINAL PRODUCT CASTOR OIL

Composition:

Active substance: castor oil (Oleum Ricini);

1 bottle contains 30 g or 100 g of castor oil.

Pharmaceutical form. Oral oil.

Main physicochemical properties: clear, thick, viscous, almost colorless or slightly yellowish liquid with a faint odor.

Pharmacotherapeutic group. Laxative. ATC code A06AB05.

Pharmacological properties.

Pharmacodynamics. When administered orally, it is hydrolyzed by lipase in the small intestine to form ricinoleic acid, which irritates intestinal receptors and reflexively enhances intestinal peristalsis. The laxative effect usually occurs within 5–6 hours. The drug also causes reflex contraction of the myometrium.

Clinical characteristics.

Indications.
Constipation.

Contraindications.

Hypersensitivity to the drug. Poisoning with fat-soluble substances (phosphorus, benzene, phenol).

Peptic ulcer of the stomach and duodenum, ulcerative colitis. Poisoning with fat-soluble anthelmintics, male fern extract. Acute inflammatory conditions within the abdominal cavity (appendicitis, peritonitis). Uterine bleeding. Cachexia. Pregnancy period. Advanced age. Pediatric age under 12 years.

Hypersensitivity to plants of the Euphorbiaceae family, undiagnosed abdominal pain, biliary tract obstruction, severe dehydration.

Special precautions.

None.

Do not violate the rules for using the medicinal product — this may harm your health.

Interaction with other medicinal products and other forms of interaction.

Concomitant use of Castor Oil with male fern extract is not recommended.

Special precautions for use.

Castor oil is a conventional herbal medicinal product for use according to indications supported by long-standing use.

The patient should consult a doctor if symptoms of the disease do not disappear during the use of the medicinal product or if adverse reactions occur that are not listed in the instructions for medical use of the medicinal product.

Use during pregnancy or breastfeeding.

The use of the product is contraindicated in pregnant women. During breastfeeding, the product should be used only if the expected benefit to the mother outweighs the possible risk to the infant.

Ability to influence reaction speed when driving or operating machinery. No data available.

Method of Administration and Dosage.

For oral use.

The recommended dose for adults and children aged 12 years and older is 15–30 g per dose.

If the drug is used for bowel cleansing prior to diagnostic procedures, it should be taken 6 hours before the procedure.

Children.

The drug is administered to children aged 12 years and older.

Overdose. Nausea, vomiting, abdominal pain, diarrhea. Treatment is symptomatic.

Adverse reactions.

Nausea, vomiting, diarrhea, abdominal pain, water-electrolyte imbalance. After bowel evacuation, constipation is possible. With prolonged use – digestive disturbances, enterocolitis, development of dependence, intestinal atony.

Allergic reactions are possible.

Shelf life. 5 years.

Storage conditions. Store in the original packaging at a temperature not exceeding 25 °C.

Keep out of reach of children.

Packaging. 30 g or 100 g in bottles.

Dispensing category. Over-the-counter.

Manufacturer. JSC "FITOPHARM" (responsible for batch release, excluding batch control/testing).

Manufacturer's address and location of its business activities.

17, Chumatska Street, Boryspil, Kyiv region, Ukraine, 08303.

Marketing Authorization Holder. JSC "FITOPHARM".

Address of the Marketing Authorization Holder.

7, Verkhovnoї Rady Boulevard, premises 18, 3rd floor, Kyiv, Ukraine, 02100.

INSTRUCTION

for medical use of the medicinal product

CASTOR OIL

Composition:

Active substance: castor oil (Oleum Ricini);

1 vial contains 30 g or 100 g of castor oil.

Pharmaceutical form. Oral oil.

Main physicochemical properties: transparent, thick, viscous, almost colorless or slightly yellowish liquid with a faint odor.

Pharmacotherapeutic group. Laxative. ATC code A06AB05.

Pharmacological properties.

Pharmacodynamics. When administered orally, it is hydrolyzed by lipase in the small intestine to form ricinoleic acid, which irritates intestinal receptors and reflexively enhances intestinal peristalsis. The laxative effect usually occurs within 5–6 hours. The drug also causes reflex contraction of the myometrium.

Clinical characteristics.

Indications.
Constipation.

Contraindications.

Hypersensitivity to the drug. Poisoning with fat-soluble substances (phosphorus, benzene, phenol).

Gastric and duodenal ulcer, ulcerative colitis. Poisoning with fat-soluble anthelmintics, male fern extract. Acute inflammatory conditions within the abdominal cavity (appendicitis, peritonitis). Uterine bleeding. Cachexia. Pregnancy. Advanced age. Pediatric age under 12 years.

Hypersensitivity to plants of the Euphorbiaceae family, undiagnosed abdominal pain, biliary tract obstruction, severe dehydration.

Special safety precautions.

None.

Do not violate the rules for using the medicinal product — this may harm your health.

Interaction with other medicinal products and other forms of interactions.

Concurrent use of castor oil with male fern extract is not recommended.

Special precautions for use

Castor oil is a conventional herbal medicinal product for use according to indications supported by long-standing use.

The patient should consult a doctor if symptoms of the disease do not disappear during the use of the medicinal product or if adverse reactions occur that are not listed in the instructions for medical use of the medicinal product.

Use during pregnancy or breastfeeding

The use of the product is contraindicated in pregnant women. During breastfeeding, the product should be used only if the expected benefit to the mother outweighs the potential risk to the infant.

Ability to influence reaction speed when driving or operating machinery
No data available.

Method of Administration and Dosage

For oral use.

The recommended dose for adults and children aged 12 years and older is 15–30 g per dose.

If the drug is used for bowel cleansing prior to diagnostic procedures, it should be administered 6 hours before the procedure.

Children.

The drug can be used in children aged 12 years and older.

Overdose.
Nausea, vomiting, abdominal pain, diarrhea. Treatment is symptomatic.

Side effects.

Nausea, vomiting, diarrhea, abdominal pain, water-electrolyte imbalance. After bowel evacuation, constipation is possible. With prolonged use – digestive disturbances, enterocolitis, development of dependence, intestinal atony.

Allergic reactions are possible.

Shelf life. 5 years.

Storage conditions. Store in the original packaging at a temperature not exceeding 25 °C.

Keep out of reach of children.

Packaging. 30 g or 100 g in bottles.

Supply category. Over-the-counter.

Manufacturer. JSC "FITOFARM".

Manufacturer's address and location of business activity.

84500, Bakhmut, Sibyrtseva St., 2, Donetsk region, Ukraine.

Marketing Authorization Holder. JSC "FITOFARM".

Address of the Marketing Authorization Holder.

7, Verkhovnoi Rady Ave., premises 18, 3rd floor, Kyiv, 02100, Ukraine.